Virtu Financial’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$46K Buy
+16,752
New +$67.6K ﹤0.01% 1263
2025
Q1
– Sell
-24,973
Closed -$76K – 2138
2024
Q4
$76K Buy
+24,973
New +$81.8K ﹤0.01% 1083
2024
Q3
– Sell
-93,186
Closed -$381K – 1959
2024
Q2
$381K Buy
+93,186
New +$1.04M 0.03% 524
2023
Q4
– Sell
-16,223
Closed -$325K – 2080
2023
Q3
$325K Buy
+16,223
New +$412K 0.03% 476
2021
Q1
– Sell
-7,142
Closed -$371K – 2104
2020
Q4
$371K Buy
+7,142
New +$322K 0.04% 546

Other funds holding ZNTL

Virtu Financial's ZNTL Position: Q3 2026 in Review

Virtu Financial opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q3 2026: 16,752 shares worth $46K. The stake represents ﹤0.01% of the portfolio and ranks #1263 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ZNTL as recently as Q4 2024.

Virtu Financial first reported a position in ZNTL in Q4 2020 and has held it in 5 quarters since. The position peaked at $381K in Q2 2024. 128 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.

  • Virtu Financial held 16,752 shares of Zentalis Pharmaceuticals worth $46K as of Q3 2026.
  • Zentalis Pharmaceuticals was a new Virtu Financial position in Q3 2026.
  • Zentalis Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q3 2026, its #1263 holding.
  • Virtu Financial first reported a position in Zentalis Pharmaceuticals in Q4 2020 and has held it in 5 quarters since.
  • Virtu Financial's Zentalis Pharmaceuticals position peaked at $381K in Q2 2024.
  • 128 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.

Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.